Abstract | BACKGROUND: METHODS: B10.S mice were sensitized with Cry j 1/ alum, then the Cry-consensus peptide was administered subcutaneously once a week for 5 weeks from the last sensitization. Histamine was dropped in both nostrils (10 microL per nostril) of each mouse on the day before continuous intranasal instillation of Cry j 1. Soon after the final challenge with Cry j 1, the mice were observed for 5 minutes for the resulting number of sneezes. In addition, serum levels of Cry j 1-specific IgE and IgG2a antibody, eosinophil infiltration in nasal tissue, and Cry j 1-specific cytokine production from splenocytes were evaluated. RESULTS: CONCLUSIONS: It was concluded that Cry-consensus peptide effectively controlled allergic responses, which results from shifting from a Th2-dominated to a Th1-dominated immune response.
|
Authors | Masako Tsunematsu, Taketo Yamaji, Daisuke Kozutsumi, Rika Murakami, Shigeki Kimura, Kohsuke Kino |
Journal | Allergology international : official journal of the Japanese Society of Allergology
(Allergol Int)
Vol. 56
Issue 4
Pg. 465-72
(Dec 2007)
ISSN: 1323-8930 [Print] England |
PMID | 17965586
(Publication Type: Journal Article)
|
Chemical References |
- Allergens
- Epitopes, T-Lymphocyte
- Membrane Proteins
- Recombinant Proteins
- Tetraspanins
- Tspan13 protein, mouse
- cry-consensus peptide
|
Topics |
- Allergens
(genetics, immunology, therapeutic use)
- Amino Acid Sequence
- Animals
- Cryptomeria
(immunology)
- Desensitization, Immunologic
- Disease Models, Animal
- Epitopes, T-Lymphocyte
(genetics, immunology)
- Female
- Humans
- Japan
- Membrane Proteins
(biosynthesis, genetics)
- Mice
- Mice, Inbred C57BL
- Molecular Sequence Data
- Pollen
(immunology)
- Recombinant Proteins
(genetics, immunology, therapeutic use)
- Rhinitis, Allergic, Seasonal
(immunology, pathology, therapy)
- Tetraspanins
|